Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
U.S.
Local
World
Science
Technology
Entertainment
Business
Sports
More
Politics
Trending on Bing
Hit record highs
Diagnosed with cancer
Lead investigator suspended
'Candid Camera' star dies
Ruling in 'Rust' hearing
'General Hospital' actor dies
No Parkinson's treatments
$1,000 for new parents?
Bloomberg donates $1B
Tire flies off during takeoff
13 missing hikers found
Neverland Ranch threatened
Napoleon’s pistols sold
VP pick likely this week
Higher education survey
TSA sets screening record
‘Rotten egg’ atmosphere
Pleads guilty in Jan. 6 attack
Housing slump deepened
Columbia removes 3 deans
Inspections over mask issue
Military land deals review
Cape Town homes destroyed
$50M deal with UConn
Violent holiday weekend
Beryl downgraded
Olympic roster announced
Says he is 'firmly committed'
New bird flu study
Fritz reaches quarterfinals
RNC's new abortion stance
Millions without power
NASCAR launches probe
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Ozempic and Cancer Risks
What to know about new study showing weight loss drugs can lower cancer risk
Clinical studies show users of the medications can lose between 5% and 20% of their body weight over time. The study authors wrote that more research is needed to determine exactly how and why GLP-1 drugs may contribute to a lower risk of obesity-associated cancers.
Ozempic and Related Drugs May Reduce Cancer Risks, Study Claims
GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
The American Journal of Managed Care
3d
GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes
Among patients with type 2 diabetes, glucagon-like peptide 1 (GLP-1) receptor agonists reduced their risk of obesity-related ...
Modern Healthcare
11d
House panel advances bill to cover weight loss drugs under Medicare
A bill to let Medicare cover popular
weight loss
drugs
like Wegovy and Ozempic passed a key committee in the House of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Wegovy
Feedback